Working... Menu
Trial record 37 of 836 for:    Advanced | Neuroendocrine Tumors

Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs (MACS2002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01590199
Recruitment Status : Completed
First Posted : May 2, 2012
Last Update Posted : April 16, 2019
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 11, 2018
  Actual Study Completion Date : September 11, 2018